Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516086 · ClinicalTrials.gov registry record · Phase 2
A 12-Week Study in Adult Subjects With Asthma
A Phase 2 study, sponsored by Dey.
- Completed
- Registry status
- Phase 2
- Development phase
- 498
- Enrollment target
NCT01516086 is a Phase 2 study that has completed, run by Dey. The registered enrollment target is 498 participants.
The verdict
NCT01516086, a Phase 2 study, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 498 participants
- Enrollment target
Study Summary
This will be a multi-center, randomized, placebo controlled parallel-group study to Replicate Efficacy of Nebulized Fluticasone Propionate (FP) in Adult Subjects with Partly Controlled and Uncontrolled Asthma. Individual participation will be approximately 16 weeks, including 12 weeks of double-blind treatment.
Interventions
- DRUG Fluticasone Propionate (FP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01516086
The ClinicalTrials.gov registry entry for NCT01516086 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 498 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dey, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluticasone Propionate (FP) is the first listed.
NCT01516086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01516086 about?
NCT01516086 is a clinical study titled "A 12-Week Study in Adult Subjects With Asthma". This will be a multi-center, randomized, placebo controlled parallel-group study to Replicate Efficacy of Nebulized Fluticasone Propionate (FP) in Adult Subjects with Partly Controlled and Uncontrolled Asthma. Individual participation will be approximately 16 weeks, including 12 weeks of double-blin...
What is the current status of trial NCT01516086?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 498 participants. The study started on 2012-03. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01516086?
The interventions under investigation include: Fluticasone Propionate (FP) (DRUG).
Who is sponsoring clinical trial NCT01516086?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.